The influence of less invasive ventricular assist device implantation on renal function | Zendy

Marcel Ricklefs | Zendy; J. Heimeshoff | Zendy; Jasmin S. Hanke | Zendy; Anamika Chatterjee | Zendy; Güneş Doğan | Zendy; Malakh Shrestha | Zendy; Christina Feldmann | Zendy; Leonhard Wert | Zendy; Axel Haverich | Zendy; Jan D. Schmitto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The influence of less invasive ventricular assist device implantation on renal function

Author(s) -

Marcel Ricklefs,

J. Heimeshoff,

Jasmin S. Hanke,

Anamika Chatterjee,

Güneş Doğan,

Malakh Shrestha,

Christina Feldmann,

Leonhard Wert,

Axel Haverich,

Jan D. Schmitto

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2017.10.03

Subject(s) - medicine , ventricular assist device , renal function , heart failure , perioperative , cardiology , creatinine , cardiorenal syndrome , thoracotomy , surgery

End-stage heart failure is associated with severe after-effects such as heart valve insufficiency, cardiac arrhythmias or end-organ dysfunctions. Renal failure or 'cardiorenal syndrome' is a critical end-organ disorder associated with advanced heart failure, which occurs due to low-output failure. Drug therapy or surgical interventions involving left ventricular assist device (LVAD) implantation may impede the progress of heart insufficiency and its after-effects including renal failure. In this study, we investigated the impact of a minimally invasive ventricular assist device implantation through upper hemisternotomy combined with anterolateral thoracotomy on renal function, in patients with perioperative renal failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research